메뉴 건너뛰기




Volumn 18, Issue 9, 2000, Pages 1837-1844

P-glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in viva in patients with P-glycoprotein- positive acute myeloid leukemia

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN DERIVATIVE; DAUNORUBICIN; DAUNORUBICINOL; DRUG METABOLITE; ETOPOSIDE; GLYCOPROTEIN P; VALSPODAR;

EID: 17644448304     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.9.1837     Document Type: Article
Times cited : (86)

References (30)
  • 1
    • 0029868247 scopus 로고    scopus 로고
    • Multidrug resistance in acute leukemia
    • Sonneveld P: Multidrug resistance in acute leukemia. Baillieres Clin Heamatol 9:185-203, 1996
    • (1996) Baillieres Clin Heamatol , vol.9 , pp. 185-203
    • Sonneveld, P.1
  • 2
    • 0031049802 scopus 로고    scopus 로고
    • Multidrug resistance in leukemia
    • McKenna SL, Padua RA: Multidrug resistance in leukemia. Br J Haematol, 96:659-674, 1997
    • (1997) Br J Haematol , vol.96 , pp. 659-674
    • McKenna, S.L.1    Padua, R.A.2
  • 3
    • 0021059566 scopus 로고
    • Multidrug-resistance phenotype in Chinese hamster ovary cells
    • Ling V, Kartner N, Sudo T, et al: Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep 67:869-874, 1983
    • (1983) Cancer Treat Rep , vol.67 , pp. 869-874
    • Ling, V.1    Kartner, N.2    Sudo, T.3
  • 4
    • 0026683638 scopus 로고
    • P-glycoprotein as multidrug transporter: A critical review of current multidrug resistant cell lines
    • Nielsen D, Skovsgaard T: P-glycoprotein as multidrug transporter: A critical review of current multidrug resistant cell lines. Biochim Biophys Acta 1139:169-183, 1992
    • (1992) Biochim Biophys Acta , vol.1139 , pp. 169-183
    • Nielsen, D.1    Skovsgaard, T.2
  • 5
    • 0021031518 scopus 로고
    • Drug resistance in Chinese hamster lung and mouse tumor cells
    • Biedler JL, Chang T, Meyers MB, et al: Drug resistance in Chinese hamster lung and mouse tumor cells. Cancer Treat Rep 67:859-867, 1983
    • (1983) Cancer Treat Rep , vol.67 , pp. 859-867
    • Biedler, J.L.1    Chang, T.2    Meyers, M.B.3
  • 6
    • 0023589312 scopus 로고
    • Genetics of multidrug resistance: Relationship of a cloned gene to the complete multidrug resistant phenotype
    • Croop JM, Guild BC, Gros P, et al: Genetics of multidrug resistance: Relationship of a cloned gene to the complete multidrug resistant phenotype. Cancer Res 47:5982-5988, 1987
    • (1987) Cancer Res , vol.47 , pp. 5982-5988
    • Croop, J.M.1    Guild, B.C.2    Gros, P.3
  • 7
    • 0020549246 scopus 로고
    • Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers
    • Tsuruo T, Iida H, Nojiri M, et al: Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res 43:2905-2910, 1983
    • (1983) Cancer Res , vol.43 , pp. 2905-2910
    • Tsuruo, T.1    Iida, H.2    Nojiri, M.3
  • 8
    • 0030003254 scopus 로고    scopus 로고
    • Reversal of multidrug resistance in acute myeloid leukemia and other haematological malignancies
    • Sonneveld P: Reversal of multidrug resistance in acute myeloid leukemia and other haematological malignancies. Eur J Cancer 32: 1062-1069, 1996
    • (1996) Eur J Cancer , vol.32 , pp. 1062-1069
    • Sonneveld, P.1
  • 9
    • 0029963038 scopus 로고    scopus 로고
    • The role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia
    • List AF: The role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 10:36-38, 1996 (suppl 1)
    • (1996) Leukemia , vol.10 , Issue.1 SUPPL. , pp. 36-38
    • List, A.F.1
  • 10
    • 0025294910 scopus 로고
    • Multidrug resistance and its circumvention
    • Beck WT: Multidrug resistance and its circumvention. Eur J Cancer 26:513-515, 1990
    • (1990) Eur J Cancer , vol.26 , pp. 513-515
    • Beck, W.T.1
  • 11
    • 0031005627 scopus 로고    scopus 로고
    • Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (mdr1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy - A Southwest Oncology Group study
    • Leith CP, Kopecky KJ, Godwin J, et al: Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (mdr1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy - A Southwest Oncology Group study. Blood 89:3323-3329, 1997
    • (1997) Blood , vol.89 , pp. 3323-3329
    • Leith, C.P.1    Kopecky, K.J.2    Godwin, J.3
  • 12
    • 0029869917 scopus 로고    scopus 로고
    • Cytogenetics and P-glycoprotein (Pgp) are independent predictors of treatment outcome in acute myeloid leukemia (AML)
    • Samdani A, Vijapurkar U, Grimm MA, et al: Cytogenetics and P-glycoprotein (Pgp) are independent predictors of treatment outcome in acute myeloid leukemia (AML). Leuk Res 20:175-180, 1996
    • (1996) Leuk Res , vol.20 , pp. 175-180
    • Samdani, A.1    Vijapurkar, U.2    Grimm, M.A.3
  • 13
    • 13344282085 scopus 로고    scopus 로고
    • Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia
    • Del Poeta G, Stasi R, Aronica G, et al: Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood 5:1997-2004, 1996
    • (1996) Blood , vol.5 , pp. 1997-2004
    • Del Poeta, G.1    Stasi, R.2    Aronica, G.3
  • 14
    • 0028923624 scopus 로고
    • Clinical studies with modulators of multidrug resistance
    • Fischer GA, Sikic BI: Clinical studies with modulators of multidrug resistance. Hematol Oncol Clin North Am 9:363-382, 1995
    • (1995) Hematol Oncol Clin North Am , vol.9 , pp. 363-382
    • Fischer, G.A.1    Sikic, B.I.2
  • 15
    • 0026051296 scopus 로고
    • P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil
    • Miller TP, Grogan TM, Dalton WS, et al: P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. J Clin Oncol 9:17-24, 1991
    • (1991) J Clin Oncol , vol.9 , pp. 17-24
    • Miller, T.P.1    Grogan, T.M.2    Dalton, W.S.3
  • 16
    • 0029074062 scopus 로고
    • Circumvention of P-glycoprotein-mediated drug resistance in human leukemic cells by non-immunosuppressive cyclosporin D analogue SDZ PSC 833
    • Jiang X-R, Kelsey SM, Wu Y-L, et al: Circumvention of P-glycoprotein-mediated drug resistance in human leukemic cells by non-immunosuppressive cyclosporin D analogue SDZ PSC 833. Br J Haematol 90:375-383, 1995
    • (1995) Br J Haematol , vol.90 , pp. 375-383
    • Jiang, X.-R.1    Kelsey, S.M.2    Wu, Y.-L.3
  • 17
    • 0026014503 scopus 로고
    • In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833
    • Boesch D, Gavériaux C, Jachez B: In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. Cancer Res 51:4226-4233, 1991
    • (1991) Cancer Res , vol.51 , pp. 4226-4233
    • Boesch, D.1    Gavériaux, C.2    Jachez, B.3
  • 18
    • 0028941366 scopus 로고
    • Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo
    • Watanabe T, Tsuge H, Oh-Hara T, et al: Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo. Acta Oncol 34:235-241, 1995
    • (1995) Acta Oncol , vol.34 , pp. 235-241
    • Watanabe, T.1    Tsuge, H.2    Oh-Hara, T.3
  • 19
    • 10344248680 scopus 로고    scopus 로고
    • Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma: A phase I study
    • Sonneveld P, Marie J-P, Huisman C, et al: Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma: A phase I study. Leukemia 10:1741-1750, 1996
    • (1996) Leukemia , vol.10 , pp. 1741-1750
    • Sonneveld, P.1    Marie, J.-P.2    Huisman, C.3
  • 20
    • 0030951875 scopus 로고    scopus 로고
    • Phase I study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemia
    • Kornblau SM, Estey E, Madden T, et al: Phase I study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemia. J Clin Oncol 15:1796-1802, 1997
    • (1997) J Clin Oncol , vol.15 , pp. 1796-1802
    • Kornblau, S.M.1    Estey, E.2    Madden, T.3
  • 21
    • 0003212704 scopus 로고    scopus 로고
    • Modulation of anthracycline resistance in poor-risk acute myeloid leukemia (AML) with SDZ PSC-833: Results of a phase I/II multicenter study
    • abstr
    • List AF, Karanes C, Dorr R, et al: Modulation of anthracycline resistance in poor-risk acute myeloid leukemia (AML) with SDZ PSC-833: Results of a phase I/II multicenter study. Blood 88:292, 1996 (suppl 1, abstr)
    • (1996) Blood , vol.88 , Issue.1 SUPPL. , pp. 292
    • List, A.F.1    Karanes, C.2    Dorr, R.3
  • 22
    • 7844224090 scopus 로고    scopus 로고
    • A phase I/II study of SDZ PSC 833 (PSC) in combination with daunorubicin (D) and cytarabine in refractory acute myelogenous leukemia (AML)
    • abstr
    • Liliemark J, Björkholm M, Udén A-M, et al: A phase I/II study of SDZ PSC 833 (PSC) in combination with daunorubicin (D) and cytarabine in refractory acute myelogenous leukemia (AML). Blood 88:292, 1996 (suppl 1, abstr)
    • (1996) Blood , vol.88 , Issue.1 SUPPL. , pp. 292
    • Liliemark, J.1    Björkholm, M.2    Udén, A.-M.3
  • 23
    • 0028245517 scopus 로고
    • Increased intracellular concentrations of doxorubicin in resistant lymphoma cells in vivo by concomitant therapy with verapamil and cyclosporin A
    • Tidefelt U, Juliusson G, Elmhorn-Rosenborg A, et al: Increased intracellular concentrations of doxorubicin in resistant lymphoma cells in vivo by concomitant therapy with verapamil and cyclosporin A. Eur J Haematol 52:276-282, 1994
    • (1994) Eur J Haematol , vol.52 , pp. 276-282
    • Tidefelt, U.1    Juliusson, G.2    Elmhorn-Rosenborg, A.3
  • 24
    • 0028827712 scopus 로고
    • P170 related multidrug resistance: Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo - A report of two cases
    • Damiani D, Michieli M, Michelutti A, et al: P170 related multidrug resistance: Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo - A report of two cases. Leukemia 9:1792-1795, 1995
    • (1995) Leukemia , vol.9 , pp. 1792-1795
    • Damiani, D.1    Michieli, M.2    Michelutti, A.3
  • 25
    • 0028958138 scopus 로고
    • Characterization of an anthracyline-resistant human promyelocyte leukemia (HL-60) cell line with an elevated mdr1 gene expression
    • Jönsson K, Dahlberg N, Tidefelt U, et al: Characterization of an anthracyline-resistant human promyelocyte leukemia (HL-60) cell line with an elevated mdr1 gene expression. Biochem Pharmacol 6:755-762, 1995
    • (1995) Biochem Pharmacol , vol.6 , pp. 755-762
    • Jönsson, K.1    Dahlberg, N.2    Tidefelt, U.3
  • 26
    • 0030790531 scopus 로고    scopus 로고
    • Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts
    • Sonneveld P, Wiemer E: Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts. Leukemia 11:1160-1165, 1997
    • (1997) Leukemia , vol.11 , pp. 1160-1165
    • Sonneveld, P.1    Wiemer, E.2
  • 27
    • 0028314667 scopus 로고
    • Comparison of the intracellular pharmacokinetics of daunorubicin and idarubicin in patients with acute leukemia
    • Tidefelt U, Sundman-Engberg B, Paul C: Comparison of the intracellular pharmacokinetics of daunorubicin and idarubicin in patients with acute leukemia. Leuk Res 18:293-297, 1994
    • (1994) Leuk Res , vol.18 , pp. 293-297
    • Tidefelt, U.1    Sundman-Engberg, B.2    Paul, C.3
  • 28
    • 0002261266 scopus 로고
    • The pharmacokinetics and bioavailability of a new chemosensitizer, SDZ PSC 833, in patients with advanced cancer
    • abstr
    • Erlichman C, Moore MJ, De Angelis C, et al: The pharmacokinetics and bioavailability of a new chemosensitizer, SDZ PSC 833, in patients with advanced cancer. Anticancer Drugs 5:44, 1994 (suppl 1, abstr)
    • (1994) Anticancer Drugs , vol.5 , Issue.1 SUPPL. , pp. 44
    • Erlichman, C.1    Moore, M.J.2    De Angelis, C.3
  • 29
    • 0030895252 scopus 로고    scopus 로고
    • th AML trial (MRC AML 10) - Adult and Childhood Leukaemia Working Parties of the Medical Research Council
    • th AML trial (MRC AML 10) - Adult and Childhood Leukaemia Working Parties of the Medical Research Council. Blood 89:2311-2318, 1997
    • (1997) Blood , vol.89 , pp. 2311-2318
    • Hann, I.M.1    Stevens, R.F.2    Goldstone, A.H.3
  • 30
    • 0030999750 scopus 로고    scopus 로고
    • Apoptosis and the dilemma of cancer chemotherapy
    • Hannun YA: Apoptosis and the dilemma of cancer chemotherapy. Blood 89:1845-1853, 1997
    • (1997) Blood , vol.89 , pp. 1845-1853
    • Hannun, Y.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.